Objective: The purpose of this study was to evaluate the clinical efficacy of preoperative vaginal intracavitary irradiation for Stage Ib2 and IIa cervical cancer.
Materials And Methods: From June 2008 to June 2014, data from 78 Stage Ib2 and IIa cervical cancer patients (age ≤75 years) with a diameter of local lesions >4 cm were collected in our hospital. Before treatment, all cases were confirmed by biopsy.
CXCL5, a CXC-type chemokine, is an important attractant for granulocytic immune cells by binding to its receptor CXCR2. Recently, CXCL5/CXCR2 has been found to play an oncogenic role in many human cancers. However, the exact role of CXCL5 in osteosarcoma cell migration and invasion has not been revealed.
View Article and Find Full Text PDFObjective: To investigate whether gemcitabine (dFdC) at the non-cytotoxic concentration enhances the effect of irradiation on human squamous carcinoma cells of the uterine cervix (HeLa) in vitro, and to evaluate the mechanism by which dFdC at the non-cytotoxic concentration [24 h 10% inhibiting concentration (IC(10))] is able to enhance radiation-induced cytotoxicity to HeLa in vitro.
Methods: The non-cytotoxic concentration (24 h IC(10)) of dFdC was determined by methyl thiazolyl tetrazolium (MTT). After exposure to the non-cytotoxic concentration (0.